Willow Biosciences Net Income
| CANSF Stock | USD 0.11 0.00 0.00% |
As of the 10th of February, Willow Biosciences maintains the Market Risk Adjusted Performance of (0.20), mean deviation of 6.12, and Downside Deviation of 10.48. Willow Biosciences technical analysis makes it possible for you to employ past prices and volume data with the intention to determine a pattern that calculates the direction of the company's future prices. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Willow Biosciences, which can be compared to its peers. Please check out Willow Biosciences information ratio, as well as the relationship between the value at risk and expected short fall to decide if Willow Biosciences is priced fairly, providing market reflects its latest price of 0.11 per share. As Willow Biosciences appears to be a penny stock we also urge to confirm its total risk alpha numbers.
Willow Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Willow Biosciences' valuation are provided below:Willow Biosciences does not presently have any fundamental gauges for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Willow |
Willow Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Willow Biosciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Willow Biosciences.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Willow Biosciences on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Willow Biosciences or generate 0.0% return on investment in Willow Biosciences over 90 days. Willow Biosciences is related to or competes with Leef Brands, C21 Investments, and Medical Developments. Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer c... More
Willow Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Willow Biosciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Willow Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.48 | |||
| Information Ratio | 0.0289 | |||
| Maximum Drawdown | 35.38 | |||
| Value At Risk | (13.33) | |||
| Potential Upside | 15.38 |
Willow Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Willow Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Willow Biosciences' standard deviation. In reality, there are many statistical measures that can use Willow Biosciences historical prices to predict the future Willow Biosciences' volatility.| Risk Adjusted Performance | 0.0417 | |||
| Jensen Alpha | 0.4704 | |||
| Total Risk Alpha | (0.59) | |||
| Sortino Ratio | 0.023 | |||
| Treynor Ratio | (0.21) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Willow Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Willow Biosciences February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0417 | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 6.12 | |||
| Semi Deviation | 6.53 | |||
| Downside Deviation | 10.48 | |||
| Coefficient Of Variation | 2454.19 | |||
| Standard Deviation | 8.33 | |||
| Variance | 69.46 | |||
| Information Ratio | 0.0289 | |||
| Jensen Alpha | 0.4704 | |||
| Total Risk Alpha | (0.59) | |||
| Sortino Ratio | 0.023 | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 35.38 | |||
| Value At Risk | (13.33) | |||
| Potential Upside | 15.38 | |||
| Downside Variance | 109.8 | |||
| Semi Variance | 42.62 | |||
| Expected Short fall | (10.97) | |||
| Skewness | 0.2034 | |||
| Kurtosis | (0.27) |
Willow Biosciences Backtested Returns
At this point, Willow Biosciences is out of control. Willow Biosciences shows Sharpe Ratio of 0.0115, which attests that the company had a 0.0115 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Willow Biosciences, which you can use to evaluate the volatility of the company. Please check out Willow Biosciences' Market Risk Adjusted Performance of (0.20), downside deviation of 10.48, and Mean Deviation of 6.12 to validate if the risk estimate we provide is consistent with the expected return of 0.1%. The firm maintains a market beta of -1.59, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Willow Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Willow Biosciences is expected to outperform it. Willow Biosciences right now maintains a risk of 8.85%. Please check out Willow Biosciences total risk alpha and the relationship between the value at risk and day median price , to decide if Willow Biosciences will be following its historical returns.
Auto-correlation | -0.25 |
Weak reverse predictability
Willow Biosciences has weak reverse predictability. Overlapping area represents the amount of predictability between Willow Biosciences time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Willow Biosciences price movement. The serial correlation of -0.25 indicates that over 25.0% of current Willow Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Willow Biosciences reported net income of (6.14 Million). This is 101.8% lower than that of the Metals & Mining sector and significantly lower than that of the Materials industry. The net income for all United States stocks is 101.08% higher than that of the company.
Willow Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Willow Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Willow Biosciences could also be used in its relative valuation, which is a method of valuing Willow Biosciences by comparing valuation metrics of similar companies.Willow Biosciences is currently under evaluation in net income category among its peers.
Willow Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (62.65) % | |||
| Current Valuation | (3.21 M) | |||
| Shares Outstanding | 123.72 M | |||
| Shares Owned By Insiders | 26.84 % | |||
| Shares Owned By Institutions | 0.12 % | |||
| Price To Earning | 4.15 X | |||
| Price To Book | 0.64 X | |||
| Price To Sales | 31.67 X | |||
| Revenue | 133 K | |||
| Gross Profit | 111 K | |||
| EBITDA | (2.92 M) | |||
| Net Income | (6.14 M) | |||
| Cash And Equivalents | 23.04 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 607 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 16.20 X | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (18.23 M) | |||
| Earnings Per Share | 0.02 X | |||
| Target Price | 2.0 | |||
| Number Of Employees | 49 | |||
| Beta | 0.99 | |||
| Market Capitalization | 10.43 M | |||
| Total Asset | 35.02 M | |||
| Z Score | 10.2 | |||
| Net Asset | 35.02 M |
About Willow Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Willow Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Willow Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Willow Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Willow OTC Stock
Willow Biosciences financial ratios help investors to determine whether Willow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.